LPA 1 ‐induced cytoskeleton reorganization drives fibrosis through CTGF‐dependent fibroblast proliferation
Year: 2013
Type: article
Abstract: There has been much recent interest in lysophosphatidic acid (LPA) signaling through one of its receptors, LPA1, in fibrotic diseases, but the mechanisms by which LPA-LPA1 signaling promotes pathological fibrosis remain to be fully elucidated. Using a mouse peritoneal fibrosis model, we demonstrate central roles for LPA and LPA1 in fibroblast proliferation. Genetic deletion or pharmacological antagonism of LPA1 protected mice from peritoneal fibrosis, blunting the increases in peritoneal collagen by 65.4 and 52.9%, respectively, compared to control animals and demonstrated that peritoneal fibroblast proliferation was highly LPA1 dependent. Activation of LPA1 on mesothelial cells induced these cells to express connective tissue growth factor (CTGF), driving fibroblast proliferation in a paracrine fashion. Activation of mesothelial cell LPA1 induced CTGF expression by inducing cytoskeleton reorganization in these cells, causing nuclear translocation of myocardin-related transcription factor (MRTF)-A and MRTF-B. Pharmacological inhibition of MRTF-induced transcription also diminished CTGF expression and fibrosis in the peritoneal fibrosis model, mitigating the increase in peritoneal collagen content by 57.9% compared to controls. LPA1-induced cytoskeleton reorganization therefore makes a previously unrecognized but critically important contribution to the profibrotic activities of LPA by driving MRTF-dependent CTGF expression, which, in turn, drives fibroblast proliferation.
Source: The FASEB Journal
DOI: 10.1096/fj.12-219378
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: green
Funders: Scleroderma Research Foundation, Coalition for Pulmonary Fibrosis, Pulmonary Fibrosis Foundation, National Institutes of Health, Japan Society for the Promotion of Science, National Heart, Lung, and Blood Institute, National Institute of Mental Health, National Institute on Drug Abuse, National Institute of Diabetes and Digestive and Kidney Diseases
Awards: Receptor-mediated S1P signaling in the embryonic brain, The role of Macrophage Delivered WNT Signaling in kidney injury and repair, The LPA Pathway in Lung Fibrosis: Novel Mediators and New Therapeutic Targets, Possible circulating permeability factors related to proteinuria in nephrotic syndrome, Receptor-mediated LPA signaling in cortical development, Protective Role of the S1P-S1P1 Pathway in Pulmonary Fibrosis, Pericyte-endothelial cross talk in vascular stability after kidney injury, G867153570, G9000115668, Center for the Study of Inflammatory Bowel Disease at Massachusetts General Hospital
OpenAlex ID: W2058357630
